Publication | Closed Access
Changes of clinical response and bone biochemical markers in patients with ankylosing spondylitis taking etanercept.
68
Citations
0
References
2007
Year
In patients with AS, etanercept therapy may be effective for reducing disease activity and improving bone biochemical markers. MMP-3 may be a useful biomarker for monitoring etanercept therapy.